These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8804158

  • 1. The relationship between adherence and liver metastatic ability in murine mastocytoma cell line.
    Sun R, Hojo H, Hashimoto Y.
    Tohoku J Exp Med; 1996 Apr; 178(4):413-24. PubMed ID: 8804158
    [Abstract] [Full Text] [Related]

  • 2. Differential production of interleukin-6 and its close relation to liver metastasis in clones from murine P815 mastocytoma.
    Hojo H, Sun R, Ono Y, Shishido T, Obara E, Yamazoe Y, Hashimoto Y.
    Cancer Lett; 1996 Nov 12; 108(1):55-9. PubMed ID: 8950209
    [Abstract] [Full Text] [Related]

  • 3. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W, Lundeen KA, Kohrumel JR, Pham NL, Brostoff SW, Bartholomew RM, Carlo DJ.
    J Immunol; 1999 Jun 15; 162(12):7343-9. PubMed ID: 10358185
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic activity of gallic acid against liver metastasis of mastocytoma cells P-815.
    Ohno T, Inoue M, Ogihara Y.
    Anticancer Res; 2001 Jun 15; 21(6A):3875-80. PubMed ID: 11911262
    [Abstract] [Full Text] [Related]

  • 5. [Massive apoptosis in P815 mastocytoma in vivo induced by interleukin 2 gene transduction].
    Guo N, Li X, Liu X.
    Zhonghua Bing Li Xue Za Zhi; 1996 Oct 15; 25(5):284-7. PubMed ID: 9388873
    [Abstract] [Full Text] [Related]

  • 6. Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences.
    Kamate C, Baloul S, Grootenboer S, Pessis E, Chevrot A, Tulliez M, Marchiol C, Viguier M, Fradelizi D.
    Int J Cancer; 2002 Aug 10; 100(5):571-9. PubMed ID: 12124807
    [Abstract] [Full Text] [Related]

  • 7. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 10; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 8. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
    Uyttenhove C, Maryanski J, Boon T.
    J Exp Med; 1983 Mar 01; 157(3):1040-52. PubMed ID: 6187879
    [Abstract] [Full Text] [Related]

  • 9. Selection and isolation of a new variant of DBA/2 mastocytoma P 815 X 2.
    Bandlow G, Härtl R.
    J Cancer Res Clin Oncol; 1989 Mar 01; 115(6):550-3. PubMed ID: 2514187
    [Abstract] [Full Text] [Related]

  • 10. Differentiation in murine mastocytoma induced by macrophage gangliosides.
    Schaade L, Thomssen R, Ritter K.
    Z Naturforsch C J Biosci; 2000 Mar 01; 55(11-12):1004-10. PubMed ID: 11204177
    [Abstract] [Full Text] [Related]

  • 11. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants.
    Maryanski JL, Marchand M, Uyttenhove C, Boon T.
    Int J Cancer; 1983 Jan 15; 31(1):119-23. PubMed ID: 6187698
    [Abstract] [Full Text] [Related]

  • 12. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice.
    Warrington RC, Cheng I, Fang WD.
    J Natl Cancer Inst; 1987 Jun 15; 78(6):1177-83. PubMed ID: 3108563
    [Abstract] [Full Text] [Related]

  • 13. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress.
    Kurihara H, Koda H, Asami S, Kiso Y, Tanaka T.
    Life Sci; 2002 Apr 21; 70(21):2509-20. PubMed ID: 12173414
    [Abstract] [Full Text] [Related]

  • 14. LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors.
    Abina MA, Lee MG, Descamps V, Cordier L, Lopez M, Perricaudet M, Haddada H.
    Gene Ther; 1996 Mar 21; 3(3):212-6. PubMed ID: 8646551
    [Abstract] [Full Text] [Related]

  • 15. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE, Fuks BB.
    Biull Eksp Biol Med; 1989 Aug 21; 108(8):194-6. PubMed ID: 2508789
    [Abstract] [Full Text] [Related]

  • 16. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL, Van Snick J, Cerottini JC, Boon T.
    Eur J Immunol; 1982 May 21; 12(5):401-6. PubMed ID: 6178607
    [Abstract] [Full Text] [Related]

  • 17. Effect of inflammatory cytokines on the adherence of tumor cells to endothelium in a murine model.
    Bereta M, Bereta J, Cohen S, Zaifert K, Cohen MC.
    Cell Immunol; 1991 Sep 21; 136(2):263-77. PubMed ID: 1908352
    [Abstract] [Full Text] [Related]

  • 18. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN, Williams RM, Benacerraf B.
    Am J Pathol; 1976 Dec 21; 85(3):661-74. PubMed ID: 826167
    [Abstract] [Full Text] [Related]

  • 19. The effect of tranexamic acid on growth and spread of an experimental tumor model.
    Teodorczyk-Injeyan J, Falk R, Ng RW, Kellen JA.
    Res Commun Chem Pathol Pharmacol; 1983 Mar 21; 39(3):515-8. PubMed ID: 6407075
    [Abstract] [Full Text] [Related]

  • 20. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL, Boon T.
    Eur J Immunol; 1982 May 21; 12(5):406-12. PubMed ID: 6178608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.